|
Volumn 16, Issue 2, 2012, Pages 192-195
|
Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments
|
Author keywords
Opsoclonus myoclonus syndrome; Paraneoplastic syndromes; Rituximab; Treatment
|
Indexed keywords
CD19 ANTIGEN;
CD5 ANTIGEN;
CORTICOTROPIN;
DEXAMETHASONE;
IMMUNOGLOBULIN G;
PREDNISONE;
RITUXIMAB;
TETRACOSACTIDE ZINC PHOSPHATE;
ALLOPATHY;
APRAXIA;
ATAXIA;
B LYMPHOCYTE;
BALANCE IMPAIRMENT;
BETA HEMOLYTIC STREPTOCOCCUS;
CASE REPORT;
CELL EXPANSION;
CEREBELLAR ATAXIA;
CONVALESCENCE;
CYTOPENIA;
DISEASE DURATION;
DISEASE EXACERBATION;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
DYSMETRIA;
FEVER;
FLOW CYTOMETRY;
FOLLOW UP;
GAIT DISORDER;
GASTROINTESTINAL INFECTION;
HERPES SIMPLEX VIRUS 1;
HERPETIC STOMATITIS;
HUMAN;
HYPOREFLEXIA;
HYPOTENSION;
INFANT;
IRRITABILITY;
MALE;
MEDICAL HISTORY;
MULTIPLE CYCLE TREATMENT;
MUSCLE HYPOTONIA;
NYSTAGMUS;
OPSOCLONUS;
OPSOCLONUS MYOCLONUS SYNDROME;
PRIORITY JOURNAL;
RELAPSE;
REVIEW;
SEROLOGY;
SLEEP DISORDER;
SPEECH DISORDER;
TREATMENT DURATION;
TREATMENT RESPONSE;
TREMOR;
VASCULITIS;
VIRUS INFECTION;
|
EID: 84857367145
PISSN: 10903798
EISSN: 15322130
Source Type: Journal
DOI: 10.1016/j.ejpn.2011.05.013 Document Type: Article |
Times cited : (21)
|
References (6)
|